FDA panel votes against Avastin, EMA gives nod – FiercePharma

Posted by on Jun 30th, 2011 and filed under Medical News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

FDA panel votes against Avastin, EMA gives nod – FiercePharma


Fox News

FDA panel votes against Avastin, EMA gives nod
FiercePharma
Regulators on both sides of the Atlantic often have contradictory opinions about the same drug. Think Avandia, the GlaxoSmithKline diabetes drug withdrawn in Europe last year on the same day the FDA chose to severely restrict it, but keep it on the
Local breast cancer researcher: FDA should keep AvastinAZFamily
After Panel's Vote, Fate of Avastin for MBC in US Rests with FDA CommissionerGenetic Engineering News
Roche's Futile Fight For a Measurable GoodWall Street Journal (blog)
Reuters –San Francisco Chronicle –Medscape
all 1,088 news articles »

Leave a Reply

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.